MediaPress Releases
 February 12, 2013

Sg2 Appoints Steve Lefar as Chief Executive Officer

SKOKIE, IL, Feb 12, 2013 (MARKETWIRE via COMTEX) — Sg2, a leading health care strategic analytics and intelligence company, today announced the promotion of Steve Lefar to chief executive officer (CEO). Lefar also will continue to serve as Sg2’s president, a role he has held for nearly two years.

Lefar will oversee all aspects of Sg2. He will be responsible for setting the company’s strategic direction and will continue to focus on expanding the company’s market-leading intelligence and analytics tools, designed to assist hospitals and health systems in understanding market dynamics and identifying business opportunities.

“Steve has helped our clients realize the potential that comes with combining their organization’s information, unique market analytics and Sg2’s expertise; simultaneously he has grown our revenue to record levels,” Sg2 founder Michael Sachs said. “His leadership has earned him the respect of the Sg2 team and his thought leadership is recognized throughout the industry.” Sachs will continue to serve as the company’s chairman.

Over the past year, Lefar has led the development and roll out of the EDGE(R) System — a seamless analytical platform for integration of market and provider information — across the Sg2’s client base.

“Sg2 has an amazing team of people and a client base that is leading and driving the industry forward,” Lefar said. “It’s an honor to be the steward of Sg2 as we continue to provide analytics and expertise to our clients as they design and execute their path forward.”

About Sg2 For over a decade, Sg2 has equipped health care leadership teams around the globe with practical expertise to navigate the ever-changing landscape of health care. Our expert led, future-focused approach, demand and revenue forecasts, strategic market analytics, education, consulting and intelligence empower clients to achieve smart growth and improve clinical performance across the continuum of care. Over 1,200 individual organizations receive Sg2’s health care services. These organizations are spread throughout the US, Europe and Asia. For more information, visit

  • Share
  • Follow Sg2 on Facebook
  • Follow Sg2 on Twitter
  • Connect with Sg2 on LinkedIn
"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."

As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets Sg2 and spend and clinical resource management segments from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.

Follow Sg2 on Twitter Connect with Sg2 on LinkedIn Watch Sg2 on YouTube